6-5 fused rings as C5a inhibitors
US10562896B2 · kind B2 · utility
8Cited by
5References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 29, 2018 |
| Grant date | Feb 18, 2020 |
| Priority date | — |
| Expiry date | May 29, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure provides, inter alia, Compounds of Formula (I) or pharmaceutically acceptable salts thereof that are modulators of the C5a receptor. Also provided are pharmaceutical compositions and methods of use including the treatment of diseases or disorders involving pathologic activation from C5a and non-pharmaceutical applications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.